JPMorgan Chase & Co. reduced its position in Teleflex Incorporated (NYSE:TFX - Free Report) by 5.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 146,748 shares of the medical technology company's stock after selling 8,410 shares during the period. JPMorgan Chase & Co. owned approximately 0.32% of Teleflex worth $26,118,000 at the end of the most recent quarter.
Other hedge funds have also bought and sold shares of the company. Avior Wealth Management LLC lifted its stake in shares of Teleflex by 81.2% in the fourth quarter. Avior Wealth Management LLC now owns 279 shares of the medical technology company's stock valued at $50,000 after buying an additional 125 shares in the last quarter. IFP Advisors Inc lifted its position in Teleflex by 238.5% in the 4th quarter. IFP Advisors Inc now owns 308 shares of the medical technology company's stock valued at $55,000 after acquiring an additional 217 shares in the last quarter. Exchange Traded Concepts LLC boosted its stake in Teleflex by 38.2% during the 4th quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company's stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. R Squared Ltd bought a new stake in Teleflex during the 4th quarter worth approximately $64,000. Finally, Kohmann Bosshard Financial Services LLC purchased a new stake in shares of Teleflex in the fourth quarter worth approximately $73,000. Institutional investors and hedge funds own 95.62% of the company's stock.
Wall Street Analysts Forecast Growth
TFX has been the subject of several recent research reports. Morgan Stanley decreased their price target on Teleflex from $275.00 to $191.00 and set an "overweight" rating for the company in a report on Wednesday, March 5th. Citizens Jmp downgraded shares of Teleflex from an "outperform" rating to a "market perform" rating in a research report on Thursday, February 27th. Needham & Company LLC reiterated a "hold" rating on shares of Teleflex in a research note on Wednesday, March 12th. StockNews.com downgraded Teleflex from a "buy" rating to a "hold" rating in a research note on Friday, February 28th. Finally, Truist Financial reduced their target price on Teleflex from $149.00 to $140.00 and set a "hold" rating for the company in a report on Friday. One analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average price target of $181.50.
Read Our Latest Stock Report on Teleflex
Teleflex Price Performance
TFX traded up $0.74 during trading on Friday, reaching $129.81. 642,249 shares of the company were exchanged, compared to its average volume of 616,652. Teleflex Incorporated has a 12-month low of $124.66 and a 12-month high of $249.91. The company's 50-day moving average is $148.00 and its two-hundred day moving average is $181.09. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. The company has a market cap of $6.02 billion, a price-to-earnings ratio of 25.81, a P/E/G ratio of 1.73 and a beta of 1.19.
Teleflex (NYSE:TFX - Get Free Report) last released its quarterly earnings data on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, beating analysts' consensus estimates of $3.86 by $0.03. The company had revenue of $795.40 million during the quarter, compared to analyst estimates of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Research analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.
Teleflex Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.05%. The ex-dividend date was Friday, March 7th. Teleflex's dividend payout ratio is 95.77%.
About Teleflex
(
Free Report)
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.
Featured Stories
Before you consider Teleflex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Teleflex wasn't on the list.
While Teleflex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
